1. Home
  2. LAZ vs OGN Comparison

LAZ vs OGN Comparison

Compare LAZ & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lazard Inc.

LAZ

Lazard Inc.

N/A

Current Price

$38.30

Market Cap

3.4B

Sector

Finance

ML Signal

N/A

Logo Organon & Co.

OGN

Organon & Co.

N/A

Current Price

$13.84

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LAZ
OGN
Founded
1848
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.6B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
LAZ
OGN
Price
$38.30
$13.84
Analyst Decision
Hold
Hold
Analyst Count
10
4
Target Price
★ $43.00
$10.33
AVG Volume (30 Days)
1.8M
★ 2.3M
Earning Date
10-22-2026
10-30-2026
Dividend Yield
★ 5.19%
0.58%
EPS Growth
★ N/A
N/A
EPS
1.20
★ 1.56
Revenue
$3,186,466,000.00
★ $6,216,000,000.00
Revenue This Year
$6.00
N/A
Revenue Next Year
$19.51
$2.07
P/E Ratio
$33.88
★ $8.87
Revenue Growth
★ 1.48
N/A
52 Week Low
$34.13
$5.69
52 Week High
$58.75
$13.88

Technical Indicators

Market Signals
Indicator
LAZ
OGN
Relative Strength Index (RSI) 51.91 60.83
Support Level $34.65 $13.72
Resistance Level $45.71 N/A
Average True Range (ATR) 1.67 0.04
MACD 0.25 0.00
Stochastic Oscillator 53.41 71.43

Price Performance

Historical Comparison
LAZ
OGN

About LAZ Lazard Inc.

Lazard Inc is a financial advisory and asset management firm with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. Geographically, the company earns key revenue in the Americas, EMEA then Asia-Pacific.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: